Kalshi Launches Prediction Markets for Biopharma Clinical Trials and Drug Approvals
Kalshi, a U.S.-based prediction market platform (KALSHI), has introduced products allowing users to place wagers on clinical trial outcomes and drug regulatory approvals. This expansion into biotech could influence investor sentiment by providing early signals about the likelihood of key events in pharmaceutical development.
Topics: biopharma clinical trials prediction market platforms regulatory approvals